Navigation Links
Mirena Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on New Mirena IUD Side Effects Study
Date:4/13/2013

New York, New York (PRWEB) April 13, 2013

As Mirena lawsuits continue to move forward in both state and federal courts, Bernstein Liebhard LLP notes that a new Mirena side effects study has found that the bleeding and spotting that sometimes occurs in the months after insertion of the levonorgestrel-releasing IUD (sold under the brand name Mirena) could not be relieved with medication. The study, published online April 5 in Obstetrics & Gynecology, was designed to identify a 25% reduction in the number of bleeding or spotting days for the first 3 months following insertion of the IUD. However, the study found that the administration of one of two drugs commonly used to treat heavy menstrual bleeding and menstrual pain only reduced the number of bleeding days by six and three, respectively.*

“This study is just another reminder of the Mirena side effects that can occur in women who use this IUD. In addition to the bleeding described in this report, our Firm has heard from numerous women who allegedly suffered more serious complications, including organ damage, infections and other problems associated with the spontaneous migration of a Mirena IUD,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free legal evaluations to women who suffered serious Mirena side effects, including uterine perforations, stemming from the migration of Mirena.

Mirena IUD Lawsuits
The Mirena IUD was approved by the U.S. Food & Drug Administration (FDA) for contraception in 2000, and in 2009, for the treatment of heavy menstrual bleeding in women who wish to use an IUD as their method of birth control.** The small, plastic t-shaped device is inserted into the uterus by a healthcare provider, where it may remain for up to 5 years, releasing a low-dose of the synthetic progestin, levonorgestrel. Since coming on the market, statistics from the FDA indicate that Mirena side effects have been cited in thousands of adverse event reports made to the agency. Device migration was the second most-common Mirena complication reported to the FDA.***

According to a Transfer Order dated April 8th, the U.S. Judicial Panel on Multidistrict Litigation has transferred all federally-filed Mirena lawsuits to U.S. District Court, Southern District of New York for pretrial proceedings. According to the Order, more than 40 Mirena IUD lawsuits have been filed in 17 federal jurisdictions, all of which allege Mirena migrated away from its original position in the uterus, leading to uterine perforations and other serious Mirena side effects. Plaintiffs further allege Bayer Healthcare Pharmaceuticals failed to provide adequate warnings regarding the risk of device migration and related side effects. (In re: Mirena IUD Products Liability Litigation, MDL No. 2434 (JPML)

Court documents also indicate that at least 47 Mirena lawsuits are pending in New Jersey Superior Court. In August 2012, Bayer filed an application with the New Jersey Supreme Court seeking the establishment of a consolidated litigation for all Mirena IUD lawsuits filed in the state in Middlesex County. While the request was rejected, plaintiffs in in those claims recently filed a new application with the Court asking it to reconsider. ****

Alleged victims of Mirena side effects caused by spontaneous migration of the IUD may be entitled to file their own Mirena lawsuit seeking compensation for medical expenses, lost wages, pain and suffering, and more. Learn more about Mirena IUD lawsuits by visiting Bernstein Liebhard LLP’s website. For additional information, please call (877) 779-1414.

*journals.lww.com/greenjournal/Abstract/publishahead/Management_of_Initial_Bleeding_or_Spotting_After.99848.aspx
**fda.gov/newsevents/newsroom/pressannouncements/2009/ucm184747.htm
***drugcite.com/?q=mirena
****judiciary.state.nj.us/mass-tort/re-app-mirena.pdff

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.mirenaiud-lawsuit.com/

Read the full story at http://www.prweb.com/releases/mirena-iud-lawsuit/mirena-side-effects/prweb10630091.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Update: Mirena Maker Asks to Keep Lawsuits With Local Court, Judge
2. Drug Center Adds News on Mirena Lawsuits: Bayer Fighting Move to Federal Court
3. The Law Firm of d'Oliveira & Associates Now Offers a No Win - No Fee Promise in Mirena IUD Cases
4. d’Oliveira & Associates Issues Webpage With Current Information On Mirena IUD Lawsuits
5. d’Oliveira & Associates Releases Mirena IUD Infographic Describing Bayer’s Deceptive Mirena Simple Style Campaign
6. Bernstein Liebhard LLP Launches Mirena IUD Lawsuit Website Providing Information on Side Effects, Growing Litigation
7. DrugRisk Announces Updated Information on Mirena Lawsuits
8. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
9. Zoloft Lawsuits: Bernstein Liebhard LLP Notes More than 300 Claims Now Pending in Federal Zoloft Birth Defects Litigation
10. Medtronic Infuse Bone Graft Lawsuits: Bernstein Liebhard LLP Notes New Report Predicting Hundreds of Medtronic Infuse Lawsuits
11. Johnson & Johnson Ethicon Transvaginal Mesh Lawsuits Update: Resource4thePeople Reports Judge Schedules More Trials for This Summer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... ... Two director-level employees of Horizon Blue Cross Blue Shield of New Jersey ... The award recognizes businesswomen who excel in their fields and who have made ... (Managed Long-Term Services and Supports) Program at Horizon NJ Health and Theresa Ponton, Director ...
(Date:5/27/2016)... ... May 27, 2016 , ... An educational ... by inspiring human-interest stories, courtesy of awareness-driven celebrities and thought leaders. It also ... advocates, associations and industry leaders such as Bioness. , As patients feel ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... ... in scholarships to students studying complementary medicine. Allison Outerbridge is this year’s ... her award on May 18 at the university’s Student Leadership Awards ceremony. , ...
(Date:5/26/2016)... ... 2016 , ... Cabot Corporation, Pfizer, and 3M are responsible ... documents and SEC filings. A jury has returned a verdict of $32.8 ... Case No. BC588866, Los Angeles County, California. The jury awarded $22.8 million in ...
(Date:5/26/2016)... ... 26, 2016 , ... The Woodlands at John Knox Village , Florida’s ... care for living and healing, celebrated its grand opening, today. The Woodlands at John ... provided by Empowered Staff. , “This is an incredibly fulfilling time for John Knox ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... FDA 510(k) clearance covers ... for urological and surgical applications Mauna ... Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) platform, ... US with the 12 th 510(k) clearance ... This new FDA clearance covers Confocal Miniprobes indicated ...
(Date:5/25/2016)... May 25, 2016  Zymo Research Corp. announced ... new reference materials that help researchers obtain the ... to analyses. The rapid growth of the study ... to have standard methods to improve the reproducibility ... inherently exist at every step of the measurement ...
(Date:5/25/2016)... 2016  Granger Diagnostics today announced immediate availability of ... infections. This test ensures discovery of ALL bacteria, ... test requires only a simple swab of the wound ... G. Bostwick , MD, Chief Medical Officer, described ... "We are excited to make available, for the ...
Breaking Medicine Technology: